Table 2.
Item/study | Alshamrani et al37 2017 | Chia et al
30 2003 |
Huang et al
29 2018 |
Kim et al
52 2016 |
Vehof et al36 2014 |
Wang et al35 2012 |
Adequate definition of cases | * | * | * | * | * | * |
Representativeness of cases | * | – | * | * | – | * |
Selection of control subjects | – | – | * | * | – | * |
Definition of control subjects | * | * | * | * | * | * |
Control for important factor or additional factor | – | – | ** | – | * | ** |
Exposure assessment | * | * | * | * | * | * |
Same method of ascertainment for all subjects | * | * | * | * | * | * |
Non-response rate | * | * | * | * | * | * |
A study could be awarded a maximum of one star for each item except for the item ‘Control for important factor or additional factor’.
The definition/explanation of each column of the Newcastle-Ottawa Scale is available from (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp).
The NOS is used to assess the methodological quality of included studies using a “star” system. A study could be awarded a maximum of one star for each item except for the item “Control for important factor or additional factor”. The “*” and “**” in table 2 actually stand for the number of stars each study can get.